These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15832106)

  • 1. Mizoribine-induced rhabdomyolysis in a rheumatoid arthritis patient receiving bezafibrate treatment.
    Morimoto S; Fujioka Y; Tsutsumi C; Masai M; Okumura T; Yuba M; Sakoda T; Tsujino T; Ohyanagi M
    Am J Med Sci; 2005 Apr; 329(4):211-3. PubMed ID: 15832106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bezafibrate-mizoribine interaction: Involvement of organic anion transporters OAT1 and OAT3 in rats.
    Feng Y; Wang C; Liu Q; Meng Q; Huo X; Liu Z; Sun P; Yang X; Sun H; Qin J; Liu K
    Eur J Pharm Sci; 2016 Jan; 81():119-28. PubMed ID: 26474691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhabdomyolysis and acute renal failure associated with bezafibrate treatment.
    Górriz JL; Sancho A; Alcoy E; García-Ramos JL; Pallardó LM
    Nephrol Dial Transplant; 1995 Dec; 10(12):2371-2. PubMed ID: 8808248
    [No Abstract]   [Full Text] [Related]  

  • 4. Severe rhabdomyolysis induced by a retard formulation of bezafibrate in a CAPD patient.
    Panuccio V; Enia G; Parlongo S; Cutrupi S; Zoccali C
    Nephron; 1996; 73(4):736. PubMed ID: 8856294
    [No Abstract]   [Full Text] [Related]  

  • 5. Rhabdomyolysis due to bezafibrate in CAPD patients. A role for dihydropyridine drugs?
    Weissgarten J; Zaidenstein R; Fishman S; Dishi V; Michovitz-Koren M; Averbukh Z; Golik A
    Perit Dial Int; 1999; 19(2):180-2. PubMed ID: 10357195
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute rhabdomyolysis after bezafibrate re-exposure.
    Terrovitou CT; Milionis HJ; Elisaf MS
    Nephron; 1998; 78(3):336-7. PubMed ID: 9546698
    [No Abstract]   [Full Text] [Related]  

  • 7. Influenza vaccine--a possible trigger of rhabdomyolysis induced acute renal failure due to the combined use of cerivastatin and bezafibrate.
    Plotkin E; Bernheim J; Ben-Chetrit S; Mor A; Korzets Z
    Nephrol Dial Transplant; 2000 May; 15(5):740-1. PubMed ID: 10809833
    [No Abstract]   [Full Text] [Related]  

  • 8. Bone scintigraphy of drug-induced rhabdomyolysis: antihyperlipidemia agent.
    Takayama T; Tsuji S; Taki J; Michigishi T; Tonami N
    Clin Nucl Med; 1996 Dec; 21(12):988-9. PubMed ID: 8957627
    [No Abstract]   [Full Text] [Related]  

  • 9. Rhabdomyolysis and acute renal failure following a switchover of therapy between two fibric acid derivatives.
    Kamaliah MD; Sanjay LD
    Singapore Med J; 2001 Aug; 42(8):368-72. PubMed ID: 11764054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bezafibrate induced rhabdomyolysis.
    Kanterewicz E; Sanmartí R; Riba J; Trias I; Autonell J; Brugués J
    Ann Rheum Dis; 1992 Apr; 51(4):536-8. PubMed ID: 1586257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of fibrate-induced rhabdomyolysis with plasma exchange in ESRD.
    Yang KC; Fang CC; Su TC; Lee YT
    Am J Kidney Dis; 2005 Mar; 45(3):e57-60. PubMed ID: 15754265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated blood concentrations of cyclosporine and kidney failure after bezafibrate in renal graft recipient.
    Hirai M; Tatuso E; Sakurai M; Ichikawa M; Matsuya F; Saito Y
    Ann Pharmacother; 1996; 30(7-8):883-4. PubMed ID: 8826580
    [No Abstract]   [Full Text] [Related]  

  • 13. A sudden onset of diabetic ketoacidosis and acute pancreatitis after introduction of mizoribine therapy in a patient with rheumatoid arthritis.
    Mori S; Ebihara K
    Mod Rheumatol; 2008; 18(6):634-8. PubMed ID: 18651203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rhabdomyolysis risk from the use of two-drug combination of antidyslipidemic drugs with antihypertensive and antidiabetic medications: a signal detection analysis.
    Gosho M
    Fundam Clin Pharmacol; 2019 Jun; 33(3):339-346. PubMed ID: 30575126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bezafibrate-induced myolysis and myoglobinuria in patients with impaired renal function].
    Rumpf KW; Barth M; Blech M; Kaiser H; Koop I; Arnold R; Scheler F
    Klin Wochenschr; 1984 Apr; 62(8):346-8. PubMed ID: 6727274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bezafibrate myopathy in two patients with chronic renal failure].
    Inoue M; Jimi T; Machida H; Niwa Y; Wakayama Y
    Rinsho Shinkeigaku; 1992 Jul; 32(7):725-8. PubMed ID: 1291164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of tacrolimus and mizoribine in a randomized, double-blind controlled study in patients with rheumatoid arthritis.
    Kawai S; Hashimoto H; Kondo H; Murayama T; Kiuchi T; Abe T
    J Rheumatol; 2006 Nov; 33(11):2153-61. PubMed ID: 16960930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of acute rhabdomyolysis and acute renal insufficiency caused by the simultaneous use of furosemide and bezafibrate].
    Venzano C; Cordi GC; Corsi L; Dapelo M; De Micheli A; Grimaldi GP
    Minerva Med; 1990 Dec; 81(12):909-11. PubMed ID: 2280884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fenofibrate monotherapy-induced rhabdomyolysis in a patient with hypothyroidism: A rare case report and literature review.
    Wang D; Wang Y
    Medicine (Baltimore); 2018 Apr; 97(14):e0318. PubMed ID: 29620657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of acute kidney injury with marked hyperuricemia during mizoribine administration.
    Nishino T; Shinzato T; Ohta Y; Yamashita H; Obata Y; Shinzato K; Kohno S
    Intern Med; 2012; 51(10):1239-43. PubMed ID: 22687797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.